| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-07 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.2 | 0.0004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.0009 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |